dc.contributorUniversidade Federal de São Paulo (UNIFESP)
dc.creatorDiehl, Alessandra
dc.creatorSilva, Rosiane Lopes da
dc.creatorLaranjeira, Ronaldo
dc.date.accessioned2015-06-14T13:45:10Z
dc.date.accessioned2019-05-24T17:11:00Z
dc.date.available2015-06-14T13:45:10Z
dc.date.available2019-05-24T17:11:00Z
dc.date.created2015-06-14T13:45:10Z
dc.date.issued2013-01-01
dc.identifierClinics. Faculdade de Medicina / USP, v. 68, n. 2, p. 205-212, 2013.
dc.identifier1807-5932
dc.identifierhttp://repositorio.unifesp.br/handle/11600/7524
dc.identifierS1807-59322013000200014.pdf
dc.identifierS1807-59322013000200014
dc.identifier10.6061/CLINICS/2013(02)OA14
dc.identifierWOS:000316764000014
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/2826776
dc.description.abstractOBJECTIVE: To estimate the prevalence of female sexual dysfunction symptoms and the associated risk factors in a sample of patients with substance-related disorders admitted to a specialized in-patient care unit. METHODS: This study used a cross-section design, with eight months of data collection, conducted with substance-dependent women using structured questionnaires to collect socio-demographic data and identify their drug of choice. The Drug Abuse Screening Test, Short Alcohol Dependence Data questionnaire, Fagerstrom Test for Nicotine Dependence, and Arizona Sexual Experience Scale were also administered. RESULTS: The sample consisted of 105 women who had a mean age of 34.8 years (SD = 12.1, range = 18-65) and were predominantly heterosexual (74.3%), single (47.6%), Caucasian (50.5%), catholic (36.2%), and educated only to the level of primary education (40%), with a monthly family income of up to one minimum salary (37.5%). In 42.9% of the patients, crack was the drug of choice; 47.6% of the sample qualified for the Drug Abuse Screening Test (substantial problems related to drugs), 43.8% exhibited Short Alcohol Dependence Data (moderate or severe dependency), 47.6% exhibited Fagerstrom Test for Nicotine Dependence (high or very high nicotine dependence). The prevalence of sexual dysfunction symptoms was 34.2% (95% CI = [25.3, 44.1]), and a high level of nicotine dependence and low income increased the chances of having sexual dysfunction by 2.72-fold and 2.54 fold, respectively. An association was also observed between female sexual dysfunction symptoms and schooling and levels of drug dependence. CONCLUSIONS: Female sexual dysfunction symptoms were common among this sample and primarily associated with high levels of nicotine use.
dc.languageeng
dc.publisherFaculdade de Medicina / USP
dc.relationClinics
dc.rightsAcesso aberto
dc.subjectSexual Dysfunction
dc.subjectSubstance-Related Disorders
dc.subjectWomen
dc.subjectCrack
dc.subjectTobacco Use Disorder
dc.titleFemale sexual dysfunction in patients with sub-stance-related disorders
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución